![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/517 | |
A61K 31/519 | |||
A61P 33/00 |
(11) | Number of the document | 2790705 |
(13) | Kind of document | T |
(96) | European patent application number | 12818825.7 |
Date of filing the European patent application | 2012-12-14 | |
(97) | Date of publication of the European application | 2014-10-22 |
(45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2012/057332 |
Date | 2012-12-14 |
(87) | Number | WO 2013/088404 |
Date | 2013-06-20 |
(30) | Number | Date | Country code |
201161576194 P | 2011-12-15 | US |
(72) |
COOKE, Nigel Graham, CH
FERNANDES GOMES DOS SANTOS, Paulo Antonio, CH
FURET, Pascal, CH
HEBACH, Christina, CH
HÖGENAUER, Klemens, CH
HOLLINGWORTH, Gregory, GB
KALIS, Christoph, CH
LEWIS, Ian, CH
SMITH, Alexander Baxter, CH
SOLDERMANN, Nicolas, CH
STAUFFER, Frédéric, CH
STRANG, Ross, CH
STOWASSER, Frank, CH
TUFILLI, Nicola, CH
VON MATT, Anette, CH
WOLF, Romain, CH
ZECRI, Frédéric, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K |
USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K |